Imidafenacin, an Antimuscarinic Agent, Improves Nocturia and Reduces Nocturnal Urine Volume
Authors:
- Osamu YokoyamaOYOsamu Yokoyama
- Yukio HommaYHYukio Homma
- Osamu YamaguchiOYOsamu Yamaguchi
- 1 September 2013
- Vol. 82 (3) , 515-520
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Antidiuretic effect of antimuscarinic agents in rat model depends on C ‐fibre afferent nerves in the bladderBJU International, 2013
- A randomized, double‐blind, placebo‐ and propiverine‐controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladderInternational Journal of Urology, 2009
- Nocturia: An austrian study on the multifactorial etiology of this symptomNeurourology and Urodynamics, 2009
- Long‐term safety, tolerability, and efficacy of the novel anti‐muscarinic agent imidafenacin in Japanese patients with overactive bladderInternational Journal of Urology, 2008
- A randomized, double‐blind, placebo‐controlled phase II dose‐finding study of the novel anti‐muscarinic agent imidafenacin in Japanese patients with overactive bladderInternational Journal of Urology, 2008
- Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptomsInternational Urogynecology Journal, 2006
- Nocturia, nocturnal polyuria, and sleep quality in the elderlyJournal of Psychosomatic Research, 2004
- Productivity, vitality and utility in a group of healthy professionally active individuals with nocturiaBJU International, 2003
- Mortality in the elderly in relation to nocturnal micturitionBJU International, 1999
- Micturition Habits of Older PeopleScandinavian Journal of Urology and Nephrology, 1992